Memantine for Refractory OCD Patients

Clinical trial NCT05015595 · UNKNOWN

Trial details

NCT number: NCT05015595
Sponsor: University of Roma La Sapienza
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Obsessive-Compulsive Disorder

Start date: 2021-09-01
Primary completion: 2022-10-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.